|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 217/00 | |
| A61K 31/47 |
| (11) | Number of the document | 1778639 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05793999.3 |
| Date of filing the European patent application | 2005-07-15 | |
| (97) | Date of publication of the European application | 2007-05-02 |
| (45) | Date of publication and mention of the grant of the patent | 2015-09-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/025193 |
| Date | 2005-07-15 |
| (87) | Number | WO 2006/020049 |
| Date | 2006-02-23 |
| (30) | Number | Date | Country code |
| 588448 P | 2004-07-15 | US |
| (72) |
MOLINO, Bruce, F., US
LIU, Shuang, US
BERKOWITZ, Barry, A., US
GUZZO, Peter, R., US
BECK, James, P., US
COHEN, Marlene, US
|
| (73) |
Albany Molecular Research, Inc.,
26 Corporate Circle, Albany, NY 12203,
US
Bristol-Myers Squibb Company, Route 206 and Province Line Road, Princeton, NJ 08543, US |
| (54) | ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN |
| ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN |